Mark E. Cooper

New-Onset Diabetes in Covid-19

Francesco Rubino, Stephanie A. Amiel, Paul Zimmet et al. · New England Journal of Medicine · 2020 · 828 citations

Medicine, Endocrinology, Internal Medicine +16

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Mark E. Cooper, Dimitria Vranes, Sherif Youssef et al. · Diabetes · 1999 · 476 citations

Medicine, Nephrology, Pathobiology +17

Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling

Stephen P. Gray, Elyse Di Marco, Kit Kennedy et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 189 citations · Full text

Life Sciences, Cell Biology, Pathobiology +16

Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis

Eoin Brennan, Bo Wang, Aaron McClelland et al. · Diabetes · 2017 · 168 citations

Life Sciences, Molecular Biology, Pathobiology +17

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

Tina Soulis, Mark E. Cooper, Dimitria Vranes et al. · Kidney International · 1996 · 157 citations · Full text

Medicine, Nephrology, Pharmacology +11